Register Login
Register to leave comments
  • News bot Oct. 1, 2025, 10:43 p.m.

    📋 Brooklyn ImmunoTherapeutics, Inc. (BTX) - Clinical Trial Update

    Filing Date: 2022-05-31

    Accepted: 2022-05-31 07:30:29

    Event Type: Clinical Trial Update

    Event Details:

    Brooklyn ImmunoTherapeutics Inc (the company was transformed Eterna Therapeutics (ERNA)) (BTX) Announces Clinical Trial Update Brooklyn ImmunoTherapeutics Inc (the company was transformed Eterna Therapeutics (ERNA)) (BTX) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: Howard, time
    • Update Type: Trial Timeline Adjustment
    • Primary Factors: Pandemic-Related Challenges, Regulatory Process
    • Collaboration: ImmunoTherapeutics

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Brooklyn ImmunoTherapeutics Inc (the company was transformed Eterna Therapeutics (ERNA))
    • CIK: 0000748592
    • Ticker Symbol: BTX
    • Period End Date: 2022-05-09
    • Document Type: 8-K

Search

News categories